Mental Health DailyResearch. Evidence. Perspective.Published research on modafinil.
Narcolepsy, a chronic neurological disorder, significantly impacts the daily lives of those affected due to excessive daytime sleepiness (EDS). Modafinil has been a cornerstone in managing E…
Read articleRecent advancements in neuropharmacology have brought to light S-CE-123, a dopamine transporter inhibitor showing remarkable promise in cognitive enhancement. Its emergence alongside R-modaf…
Read articleIn the pursuit of peak mental performance, scientific studies have explored the effects of stimulants like methylphenidate, modafinil, and caffeine on cognitive functions such as memory and …
Read articleModafinil (brand name “Provigil”) is a blockbuster eugeroic drug synthesized by Cephalon Pharmaceuticals (now Teva) and approved in 1998 for the treatment of excessive daytime sleepiness (ED…
Read articleHydrafinil (Fluorenol) is an unregulated research chemical originally synthesized by Cephalon Pharmaceuticals (now owned by Teva) as a eugeroic (wakefulness-promoting agent). After its synth…
Read articleProvigil (Modafinil) is a eugeroic drug that was originally approved in 1998 for the treatment of excessive daytime sleepiness associated with narcolepsy, shift work sleep disorder, and obst…
Read articleProvigil (modafinil) is a drug that was approved in 1998 for the treatment of excessive daytime sleepiness associated with narcolepsy. It has since been granted FDA approval for the treatmen…
Read article
